Literature DB >> 18559572

Risk of second primary cancer among esophageal cancer patients: a pooled analysis of 13 cancer registries.

Shu-Chun Chuang1, Mia Hashibe, Ghislaine Scelo, David H Brewster, Eero Pukkala, Soren Friis, Elizabeth Tracey, Elisabete Weiderpass, Kari Hemminki, Sharon Tamaro, Kee-Seng Chia, Vera Pompe-Kirn, Erich V Kliewer, Jon M Tonita, Carmen Martos, Jon G Jonasson, Carolyn M Dresler, Paolo Boffetta, Paul Brennan.   

Abstract

BACKGROUND: The objective of this study is to assess the risk of second primary cancers following a first primary esophageal cancer as well as the risk of esophageal cancer as a second primary, following first primary cancers of other sites.
METHODS: The present investigation is a multicenter study of 13 population-based cancer registries in Europe, Australia, Canada, and Singapore. To assess excess occurrence of second cancers after esophageal cancers, we calculated standardized incidence ratios (SIR) by dividing the observed numbers of second cancers by the expected number of cancers calculated from the accumulated person-years and the age-, sex-, calendar period-, and registry-specific first primary cancer incidence rates.
RESULTS: During the study period, 959 cases of second primary cancers occurred after an initial esophageal cancer, resulting in a SIR of 1.15 (95% confidence interval, 1.08-1.22). Second primary stomach cancers were associated with first primary esophageal adenocarcinomas (SIR, 2.13; 95% confidence interval, 1.26-3.37) and second primary cancers of the oral cavity and pharynx (6.68; 5.33-8.26), stomach (1.53; 1.14-2.01), larynx (3.24; 1.88-5.18), lung (1.55; 1.28-1.87), kidney (1.88; 1.18-2.85), and thyroid (2.92; 1.18-6.02) were associated with first primary squamous cell carcinomas of the esophagus. An excess of esophageal cancer as a second primary were observed following first primary cancers of the aerodigestive tract, female breast, cervix, testis, bladder, Hodgkin's lymphoma, and non-Hodgkin lymphoma.
CONCLUSION: We observed associations of esophageal cancer with second primary head and neck cancers and lung cancer regardless of years of follow-up, which may suggest that common risk factors play a role in multiple tumor development.

Entities:  

Mesh:

Year:  2008        PMID: 18559572     DOI: 10.1158/1055-9965.EPI-07-2876

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  33 in total

1.  Current status of esophageal endoscopy including the evaluation of smoking and alcohol consumption in Japan: an analysis based on the Japan endoscopy database.

Authors:  Chikatoshi Katada; Takahiro Horimatsu; Manabu Muto; Kiyohito Tanaka; Koji Matsuda; Mitsuhiro Fujishiro; Yutaka Saito; Kazuo Ohtsuka; Ichiro Oda; Masayuki Kato; Mitsuhiro Kida; Kiyonori Kobayashi; Shu Hoteya; Shinya Kodashima; Takahisa Matsuda; Hironori Yamamoto; Shomei Ryozawa; Ryuichi Iwakiri; Hiromu Kutsumi; Hiroaki Miyata; Mototsugu Kato; Ken Haruma; Kazuma Fujimoto; Naomi Uemura; Michio Kaminishi; Hisao Tajiri
Journal:  Esophagus       Date:  2018-12-05       Impact factor: 4.230

2.  Incidence and prognostic significance of second primary cancers in renal cell carcinoma.

Authors:  Subhankar Chakraborty; Stefano R Tarantolo; Surinder K Batra; Ralph J Hauke
Journal:  Am J Clin Oncol       Date:  2013-04       Impact factor: 2.339

3.  Clinical presentations of thyroid cancer patients with multiple primary cancers.

Authors:  J D Lin; K J Lin; T C Chao; C Hseuh; N M Tsang; B Y Huang
Journal:  J Endocrinol Invest       Date:  2011-05-24       Impact factor: 4.256

4.  Newly developed primary malignancies in long-term survivors who underwent curative esophagectomy for squamous cell carcinoma of the esophagus.

Authors:  Dai Shimizu; Masahiko Koike; Mitsuro Kanda; Fuminori Sonohara; Norifumi Hattori; Masamichi Hayashi; Chie Tanaka; Suguru Yamada; Yasuhiro Kodera
Journal:  Surg Today       Date:  2020-07-07       Impact factor: 2.549

5.  Successful treatment of quintuple primary cancer, including esophageal cancer: A case report.

Authors:  Yasunori Otowa; Tetsu Nakamura; Gosuke Takiguchi; Naoki Urakawa; Ryo Ishida; Tatsuya Imanishi; Satoshi Suzuki; Kenichi Tanaka; Daisuke Kuroda; Yoshihiro Kakeji
Journal:  Oncol Lett       Date:  2015-03-27       Impact factor: 2.967

6.  Prevalence of lung tumors in patients with esophageal squamous cell carcinoma and vice versa: a systematic review and meta-analysis.

Authors:  Laurelle van Tilburg; Steffi E M van de Ven; Manon C W Spaander; Laurens A van Kleef; Robin Cornelissen; Marco J Bruno; Arjun D Koch
Journal:  J Cancer Res Clin Oncol       Date:  2022-06-23       Impact factor: 4.553

Review 7.  Molecular mechanisms of ethanol-associated oro-esophageal squamous cell carcinoma.

Authors:  Yao Liu; Hao Chen; Zheng Sun; Xiaoxin Chen
Journal:  Cancer Lett       Date:  2015-03-09       Impact factor: 8.679

8.  Bladder cancer in cancer patients: population-based estimates from a large Swedish study.

Authors:  J Lorenzo Bermejo; J Sundquist; K Hemminki
Journal:  Br J Cancer       Date:  2009-09-15       Impact factor: 7.640

Review 9.  Surgical strategies for esophageal cancer associated with head and neck cancer.

Authors:  Masaru Morita; Hiroshi Saeki; Shuhei Ito; Yasue Kimura; Nami Yamashita; Koji Ando; Yukiharu Hiyoshi; Eriko Tokunaga; Eiji Oki; Tetsuo Ikeda; Sei Yoshida; Torahiko Nakashima; Yoshihiko Maehara
Journal:  Surg Today       Date:  2013-08-30       Impact factor: 2.549

10.  The incidence and risk of developing a second primary esophageal cancer in patients with oral and pharyngeal carcinoma: a population-based study in Taiwan over a 25 year period.

Authors:  Kuan-Der Lee; Chang-Hsien Lu; Ping-Tsung Chen; Chunghuang Hubert Chan; Jen-Tsun Lin; Cih-En Huang; Chih-Cheng Chen; Min-Chi Chen
Journal:  BMC Cancer       Date:  2009-10-20       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.